Chronic myeloid leukemia in a patient with acquired immune deficiency syndrome: Complete cytogenetic response with imatinib mesylate: Report of a case and review of the literature

Apostolia Maria Tsimberidou, Jorge Medina, Jorge Cortes, Adan Rios, Glisson Bonnie, Stefan Faderl, Hagop Kantarjian, Guillermo Garcia-Manero

Research output: Contribution to journalArticle

10 Scopus citations


We report a patient with acquired immune deficiency syndrome (AIDS) who developed Philadelphia-positive chronic myeloid leukemia (CML) and was successfully treated with imatinib mesylate. He achieved a complete cytogenetic response after 7 months of treatment. It appears that there is no in vivo interaction between imatinib and highly active anti-retroviral therapy (HAART) and these drugs can be concurrently administered with safety to patients with CML and AIDS.

Original languageEnglish (US)
Pages (from-to)657-660
Number of pages4
JournalLeukemia Research
Issue number6
StatePublished - Jun 1 2004
Externally publishedYes



  • Acquired immune deficiency syndrome
  • Chronic myeloid leukemia
  • Imatinib mesylate

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this